KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stereotaxis (STXS) Shares Outstanding (Diluted Average) (2016 - 2025)

Stereotaxis (STXS) has disclosed Shares Outstanding (Diluted Average) for 11 consecutive years, with $92.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 7.21% to $92.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $92.0 million, a 7.21% increase, with the full-year FY2024 number at $85.2 million, up 5.55% from a year prior.
  • Shares Outstanding (Diluted Average) was $92.0 million for Q3 2025 at Stereotaxis, up from $88.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $92.0 million in Q3 2025 to a low of $75.2 million in Q1 2021.
  • A 5-year average of $80.4 million and a median of $78.8 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Peak YoY movement for Shares Outstanding (Diluted Average): increased 0.37% in 2022, then increased 9.12% in 2024.
  • Stereotaxis' Shares Outstanding (Diluted Average) stood at $75.6 million in 2021, then grew by 0.67% to $76.1 million in 2022, then rose by 6.1% to $80.7 million in 2023, then grew by 5.55% to $85.2 million in 2024, then increased by 8.02% to $92.0 million in 2025.
  • Per Business Quant, the three most recent readings for STXS's Shares Outstanding (Diluted Average) are $92.0 million (Q3 2025), $88.0 million (Q2 2025), and $87.8 million (Q1 2025).